Related Experiment Video
Updated: Aug 19, 2026

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Mechanism of premature polypetide termination in a mouse ascites cell-free system programmed by encephalomyocarditis
Abstract:
The premature termination and release of encephalomyocarditis viral RNA-programmed polypeptides were analyzed in a cell-free system from mouse ascites tumor cells. The KCL concentration affects the size distribution of products but not the extent of polypeptide release. The same major products (60,000 to 140,000 molecular weight) are found in both the soluble and particulate fractions. The majority of released polypeptides are free protein, whereas the ribosome-bound product is mostly in the form of peptidyl-tRNA.
Insights
This study analyzed encephalomyocarditis virus RNA-programmed polypeptide release in a cell-free system. Polypeptide release was independent of KCl concentration, with products found in both soluble and particulate fractions.
Area of Science:
- Molecular Biology
- Virology
Background:
- Encephalomyocarditis virus (EMCV) replication involves the translation of a large precursor polyprotein.
- Understanding the mechanisms of premature termination and release of viral polypeptides is crucial for comprehending viral replication strategies.
Purpose of the Study:
- To investigate the premature termination and release of encephalomyocarditis viral RNA-programmed polypeptides.
- To analyze the characteristics of these released polypeptides and their association with cellular fractions.
Main Methods:
- Utilized a cell-free system derived from mouse ascites tumor cells.
- Analyzed polypeptide products using molecular weight determination.
- Fractionated products into soluble and particulate components.
Main Results:
- KCl concentration influenced the size distribution of translation products but not the overall extent of polypeptide release.
- Major polypeptide products, ranging from 60,000 to 140,000 molecular weight, were identified in both soluble and particulate fractions.
- The majority of released polypeptides existed as free proteins, while ribosome-bound products were predominantly in the form of peptidyl-tRNA.
Conclusions:
- Premature termination and release of EMCV polypeptides occur in a cell-free system.
- The process is influenced by salt concentration regarding product size but not release extent.
- Distinction between free protein and peptidyl-tRNA forms highlights different stages of translation termination and release.
Related Concept Videos
Nuclear Export of mRNA
Termination of Translation
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Leaky Scanning
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Experimental RNAi

